Michal M. Lotem
Jerusalem, JM, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
UV irradiation drives lineage-specific MITF-mediated transcription of PD-L1 to confer immune tolerance to UV-mutated melanocytes.
Journal: Immunity
Published: September 03, 2026
Corrigendum to Interferon Alpha-2a as Treatment for Primary Acquired Melanosis With Atypia and for Primary Acquired Melanosis With Atypia Surrounding Conjunctival Melanoma. Am J Ophthalmol. 2026;285:318-323.
Journal: American journal of ophthalmology
Published: August 14, 2026
Author Correction: The evolving role of cytokines for CAR-T cell manufacturing and beyond.
Journal: Nature biomedical engineering
Published: August 10, 2026
Reply to Comment on: Interferon alpha-2a as treatment for primary acquired melanosis with atypia and for primary acquired melanosis with atypia surrounding conjunctival melanoma.
Journal: American journal of ophthalmology
Published: April 25, 2026
Prediction of clinical outcomes of advanced cutaneous squamous cell carcinoma to PD-1 inhibition directly from histopathology slides using inferred transcriptomics.
Journal: Frontiers in immunology
Published: March 03, 2026
Impact of COVID-19 on cutaneous squamous cell carcinoma severity in a tertiary referral center in Israel: Lessons for future pandemics.
Journal: JAAD international
Published: November 17, 2025
Interferon Alpha-2a as Treatment for Primary Acquired Melanosis With Atypia and for Primary Acquired Melanosis With Atypia Surrounding Conjunctival Melanoma.
Journal: American journal of ophthalmology
Published: November 01, 2025
The evolving role of cytokines for CAR-T cell manufacturing and beyond.
Journal: Nature biomedical engineering
Published: February 17, 2025
Facts and Hopes: Toward the Next Quantum Leap in Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 22, 2025
HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion.
Journal: Cell
Published: January 08, 2025
Last Updated: 09/26/2026